Identification of novel p53 target genes by cDNA AFLP in glioblastoma cells

Mojtaba Saffari1, Orkideh Saydi Dinehkabodi, Seyed Hamid Ghaffari

  • 1Department of Medical Genetics, Tehran University of Medical Sciences, Pour Sina Avenue, Tehran, Iran.

Cancer Letters
|September 26, 2008
PubMed

Insights

Overexpressing wild-type p53 (wt-p53) in glioblastoma cells suppressed Cathepsin B and Caprin-I genes while overexpressing Annexin-II. These genes may mediate p53-driven tumor growth suppression.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • The p53 tumor suppressor protein is crucial for regulating cell cycle arrest and apoptosis.
  • Glioblastoma is an aggressive brain tumor with complex genetic alterations.
  • Understanding p53's role in glioblastoma is vital for developing targeted therapies.

Purpose of the Study:

  • To investigate the effect of wild-type p53 (wt-p53) overexpression on gene expression in U87 glioblastoma cells.
  • To identify potential mediators of p53-dependent tumor growth suppression.
  • To explore the molecular mechanisms underlying p53's function in glioblastoma.

Main Methods:

  • Overexpression of wt-p53 in U87 glioblastoma cells using a recombinant adenovirus (Ad-GFP-P53).
  • Transcript profiling using cDNA amplified fragment length polymorphism (cDNA-AFLP).
  • Validation of gene expression changes using semi-quantitative RT-PCR and DNA sequencing.

Main Results:

  • Overexpression of wt-p53 led to the suppression of Cathepsin B and cell cycle associated protein-1 (Caprin-I) gene expression.
  • Annexin-II gene expression was found to be upregulated in response to wt-p53 overexpression.
  • Specific gene expression changes were observed in glioblastoma cells following wt-p53 introduction.

Conclusions:

  • Cathepsin B, Caprin-I, and Annexin-II are potential downstream effectors of p53 signaling in glioblastoma.
  • These identified genes may play significant roles in mediating the tumor suppressor functions of p53.
  • Further research into these genes could reveal novel therapeutic targets for glioblastoma treatment.

Related Concept Videos